<DOC>
	<DOCNO>NCT00436293</DOCNO>
	<brief_summary>Primary objective : To assess compare toxicity patient advance NPC treat concurrent cisplatin-radiotherapy without neoadjuvant Taxotere ( docetaxel ) cisplatin . Secondary objective : To assess tumor control survival</brief_summary>
	<brief_title>Taxotere + Cisplatin Nasopharyngeal Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>International Union Cancer stag III IV newly diagnose NPC Inadequate bone marrow reserve Inadequate renal function Other primary malignancy Evidence distant metastases The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>